RYHAX Mutual Fund

RYHAX Mutual Fund

NAV$128.15
See how much of RYHAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$1M
Expense Ratio
1.64%
Dividend Yield (Current)
-
Holdings
136
Inception Date
May 11, 1998
Fund Family
Rydex Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+11.59%
1 Year+22.37%
3 Year+11.56%
5 Year+4.48%
10 Year+9.67%

Asset Allocation

Stocks: 99.03%
Other: 0.97%
See how much of RYHAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.4.07%
JNJJohnson & Johnson - Common3.40%
ABBVAbbvie Inc.2.94%
UNHUnitedhealth Group Incorporated2.59%
MRKMerck & Company Inc2.42%
Top 10 Concentration: 24.72%Report Date: Jul 31, 2026
Download all 136 holdings for RYHAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$1.41
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

RYHAX Mutual Fund Overview

RYHAX Mutual Fund (Rydex Health Care Fund Class H) is managed by Rydex Funds with $1.1M in net assets. RYHAX expense ratio is 1.64%, holding 136 positions across sectors including Health Care, Financials, Information Technology. Inception date: 1998-05-11.

RYHAX performance shows a YTD return of 11.59%. The 1-year return is 22.37% and the 5-year return is 4.48%.

RYHAX top holdings include Eli Lilly & Co. (4.1%), Johnson & Johnson - Common (3.4%), Abbvie Inc. (2.9%), Unitedhealth Group Incorporated (2.6%), Merck & Company Inc (2.4%). Go to all RYHAX holdings, RYHAX sectors, or RYHAX dividends.

RYHAX can be compared against other funds. Use RYHAX overlap to find shared positions, or RYHAX vs another fund for a side-by-side view. RYHAX alternatives are available via the screener, along with tax-loss harvesting opportunities.